It is a very good question, because we spent weeks asking that same question.
One of the reasons they and other countries with universal pharmacare make it sustainable is they're paying much less. We're getting a lot of push-back; I'm seeing it indirectly. I think all advocacy groups and all patients need to be aware. We're getting push-back from the pharmaceutical industry. Never mind pharmacare; they are saying right now that if Canada goes through with its plans to decrease what we pay for drugs, it's going to inhibit research and development. It will decrease the number of new drugs, and in their very words, will put Canadians' lives at risk. We are hearing that.